Faust R A, Albers J J
Department of Medicine, University of Washington School of Medicine, Seattle 98104.
J Biol Chem. 1988 Jun 25;263(18):8786-9.
We have investigated the human CaCo-2 enterocyte model for secretion of the plasma cholesteryl ester transfer protein, LTP-I. CaCo-2 cells secrete a cholesteryl ester transfer protein which possesses molecular identity with plasma LTP-I, demonstrated by anti-LTP-I immunoblot analysis and immunoinhibition of all cell-secreted cholesteryl ester transfer activity. When CaCo-2 are cultured on permeable membranes, cholesteryl ester transfer activity is detected only in the lower culture compartment. Thus, CaCo-2 vectorially sort and secrete LTP-I, as well as the intestinal apolipoproteins, from the basolateral cellular domain. Over a 24-h period, CaCo-2 secrete cholesteryl ester transfer activity in a time-dependent manner, at approximately twice the rate of HepG2. Furthermore, CaCo-2 enterocytes, but not HepG2 hepatocytes, regulate LTP-I secretion in response to fatty acid concentration in the culture medium. Based on these observations, we speculate that the intestine may be the principal regulated source of human plasma LTP-I.
我们研究了人CaCo-2肠上皮细胞模型分泌血浆胆固醇酯转运蛋白LTP-I的情况。CaCo-2细胞分泌一种胆固醇酯转运蛋白,通过抗LTP-I免疫印迹分析和对所有细胞分泌的胆固醇酯转运活性的免疫抑制证明,该蛋白与血浆LTP-I具有分子同一性。当CaCo-2细胞在可渗透膜上培养时,仅在下层培养室中检测到胆固醇酯转运活性。因此,CaCo-2细胞从基底外侧细胞结构域定向分选并分泌LTP-I以及肠载脂蛋白。在24小时内,CaCo-2细胞以时间依赖性方式分泌胆固醇酯转运活性,速率约为HepG2细胞的两倍。此外,CaCo-2肠上皮细胞而非HepG2肝细胞会根据培养基中脂肪酸浓度调节LTP-I的分泌。基于这些观察结果,我们推测肠道可能是人类血浆LTP-I的主要调节来源。